Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yasser Khder"'
Autor:
Tzu-Fei Wang, Alok A Khorana, Giancarlo Agnelli, Dan Bloomfield, Marc P Bonaca, Harry R Büller, Jean M Connors, Shinya Goto, Zhi-Cheng Jing, Ajay K Kakkar, Yasser Khder, Gary E Raskob, Gerald A Soff, Peter Verhamme, Jeffrey I Weitz, Marc Carrier
Publikováno v:
The Oncologist.
Cancer-associated thrombosis, with the incidence rising over the years, is associated with significant morbidity and mortality in patients with cancer. Recent advances in the treatment of cancer-associated venous thromboembolism (VTE) include the int
Autor:
Viviane Klingmann, Markus Hinder, Thomas H Langenickel, Fabian Chen, Yasser Khder, Jörg Breitkreutz, Hans Martin Bosse
Publikováno v:
Archives of Disease in Childhood. :archdischild-2022
ObjectivesDrug treatment of children is often limited to liquid formulations or manipulation of adult solid oral dosage forms because of the lack of age-appropriate formulations, concerns around particle aspiration and paediatric acceptability. Recen
Autor:
Andras Gruber, Dan Bloomfield, Yasser Khder, Michael Wallisch, Erik I. Tucker, Monica T. Hinds
Publikováno v:
Blood. 138:1027-1027
Background: Factor XI (FXI) inhibition demonstrated strong efficacy in preventing thrombus formation in preclinical and clinical models of arterial and venous thrombosis. However, the effect of FXI inhibition in halting the progression of a formed cl
Autor:
Meike Scharenberg, Serge Côté, Carsten Krantz, Craig T. Basson, Keith DiPetrillo, Stefan Ewert, Janeen M Salter, Brian Stoll, Geraldine Horny, Simone Schleeger, Yu-Hsin Chiu, Julie DeGagne, Peter Hoffmann, Andreas Hein, Jianying Yu, Peter McCormack, Zhiping Chen, Paul Ramage, Nikolaus Schiering, Frederic Villard, Yasser Khder, Samu Melkko, Jörg Eder, Ulrich Hassiepen, Yiming Zhang, Lionel Muller, Xueming Huang, Robert J. A. Frost, Kenneth Kulmatycki, Alexander W. Koch, David Louis Feldman
Publikováno v:
Blood. 133(13)
A large unmet medical need exists for safer antithrombotic drugs because all currently approved anticoagulant agents interfere with hemostasis, leading to an increased risk of bleeding. Genetic and pharmacologic evidence in humans and animals suggest
Publikováno v:
Heart Failure ISBN: 9783319596587
It has been known since the 1990s that long-term morbidity and mortality is improved in patients with heart failure with reduced ejection fraction (HFrEF) by treatments that target the renin–angiotensin–aldosterone system (RAAS). It has also long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bc11f5b34ec80a7f5c3ccd083bd4ea3
https://doi.org/10.1007/164_2016_77
https://doi.org/10.1007/164_2016_77
Publikováno v:
Clinical Therapeutics. 27:578-588
Recent antihypertensive treatment guidelines recommend greater use of combination therapies.The primary objective of this study was to determine whether combination therapy with valsartan 160 mg plus hydrochlorothiazide (HCTZ) 25 mg OD would be more
Publikováno v:
American Journal of Hypertension. 10:269-274
The radial artery compliance may be paradoxically increased in untreated arterial hypertension. However, the effect of blood pressure normalization on the radial artery compliance is not well known. We performed a cross-sectional study in order to in
Autor:
Tim Eisen, Igor Bondarenko, Arsene-Bienvenu Loembe, Claudia Dallinger, Yaroslav Shparyk, Robert Jones, Matus Studeny, Yasser Khder, Graham Temple, Gudrun Wallenstein, N. MacLeod
Publikováno v:
Investigational new drugs. 31(5)
Purpose Some targeted anticancer agents are associated with serious ventricular tachyarrhythmias, which may be predicted by electrocardiographic evaluation of drug-related QT prolongation. We studied the effects of nintedanib (BIBF 1120; an oral, tri
Autor:
John W, Eikelboom, Stuart J, Connolly, Martina, Brueckmann, Christopher B, Granger, Arie P, Kappetein, Michael J, Mack, Jon, Blatchford, Kevin, Devenny, Jeffrey, Friedman, Kelly, Guiver, Ruth, Harper, Yasser, Khder, Maximilian T, Lobmeyer, Hugo, Maas, Jens-Uwe, Voigt, Maarten L, Simoons, Frans, Van de Werf, J, Rogowski
Publikováno v:
New England Journal of Medicine, 369(13), 1206-1214. Massachussetts Medical Society
New England journal of medicine, 369(13), 1206-1214. Massachussetts Medical Society
New England journal of medicine, 369(13), 1206-1214. Massachussetts Medical Society
BackgroundDabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alternative to warfarin in patients with atrial fibrillation. We evaluated the use of dabigatran in patients with mechanical heart valves. MethodsIn this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4d96d1188472d4b299f2fb1f5268a2
https://pure.eur.nl/en/publications/1274a6e4-557a-4f4a-8a19-5e00d49fbd23
https://pure.eur.nl/en/publications/1274a6e4-557a-4f4a-8a19-5e00d49fbd23
Publikováno v:
International Journal of Cardiology. 56:149-158
The viscoelastic, muscular and endothelial components of the vessel wall may be altered in patients with congestive heart failure (CHF). In order to investigate the relative contribution of each of these components to the peripheral vascular mechanis